Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a report published on Thursday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Up 2.6 %

Shares of NYSE RVP opened at $1.17 on Thursday. The stock has a market cap of $35.03 million, a P/E ratio of -4.50 and a beta of 2.07. The business’s fifty day simple moving average is $1.07 and its 200-day simple moving average is $1.14. Retractable Technologies has a 12-month low of $0.87 and a 12-month high of $1.34. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%. The company had revenue of $7.60 million for the quarter.

Insider Buying and Selling at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw bought 48,635 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were purchased at an average price of $1.03 per share, with a total value of $50,094.05. Following the completion of the acquisition, the chief executive officer now directly owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In the last three months, insiders have bought 138,978 shares of company stock valued at $142,065. Insiders own 55.00% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.